The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
GeneEdit Therapeutics Raises $2.0B Series F for Revolutionary Gene Therapy Technology
GeneEdit Therapeutics secures $2.0B in Series F funding at $29.5B valuation to pioneer breakthrough gene therapy technology.
BioPharmaceuticals Next Secures $1.6B Series E to Lead Pharmaceuticals Innovation
BioPharmaceuticals Next raises $1.6B in Series E funding at $24.3B valuation to advance 12 drug candidates through clinical trials, scale gene therapy manufacturing, and expand personalized medicine programs.
BioAge Therapeutics Raises $350M Series C to Transform Healthcare
BioAge Therapeutics secures $350M in Series C funding at $4.3B valuation to advance anti-aging drug trials, expand research into age-related diseases, and scale manufacturing for clinical studies.
LifeExtension Unlimited Secures $2.9B Series G for Cosmic-Scale Extreme Longevity Technology
LifeExtension Unlimited achieves $2.9B in Series G funding at $43.6B valuation to pioneer revolutionary extreme longevity technology that could transform human civilization.
Showing 4 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.